Nyrstar N.V. | Small-cap | Basic Materials
€0.07
5.79%
| Nyrstar N.V Stock Comparison:
Nyrstar N.V vs Syneos HealthNyrstar N.V vs Azelis Group NVNyrstar N.V vs Solvay SANyrstar N.V vs Titan CementNyrstar N.V vs Solvac S.ANyrstar N.V vs BEL 20 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 13.3M
Total Liabilities 21.8M
Shareholders Equity -8.4M

Cash Flow Metrics

Revenue & Profitability Trend

Nyrstar N.V Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i00000
Cost of Goods Sold i5.0M5.1M4.1M3.5M4.2M
Gross Profit i-5.0M-5.1M-4.1M-3.5M-4.2M
Gross Margin % i0.0%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i-4.1K-10.5K-5.9K-33.4K43.4K
Total Operating Expenses i-4.1K-10.5K-5.9K-33.4K43.4K
Operating Income i-5.0M-5.0M-4.0M-3.4M-4.3M
Operating Margin % i0.0%0.0%0.0%0.0%0.0%
Non-Operating Items
Interest Income i460.9K386.5K33.8K-0
Interest Expense i428.1K367.7K77.2K34.9K21.1K
Other Non-Operating Income-----
Pre-tax Income i-4.5M-1.5M-848.3K-959.1K-11.7M
Income Tax i----2.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-4.5M-1.5M-848.3K-959.1K-11.7M
Net Margin % i0.0%0.0%0.0%0.0%0.0%
Key Metrics
EBITDA i-4.5M-4.6M-4.0M-3.4M-4.3M
EPS (Basic) i€-0.04€-0.01€-0.01€-0.01€-0.11
EPS (Diluted) i€-0.04€-0.01€-0.01€-0.01€-0.11
Basic Shares Outstanding i-109873001109873001109873001109873001
Diluted Shares Outstanding i-109873001109873001109873001109873001

Income Statement Trend

Nyrstar N.V Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i1.5M1.9M2.8M62.8K601.4K
Short-term Investments i11.0M13.0M15.0M15.4M15.4M
Accounts Receivable i-----
Inventory i-----
Other Current Assets-----
Total Current Assets i13.3M16.2M18.8M16.1M17.0M
Non-Current Assets
Property, Plant & Equipment i-----
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i00000
Total Assets i13.3M16.2M18.8M16.1M17.0M
Liabilities
Current Liabilities
Accounts Payable i343.0K501.0K540.5K267.6K1.2M
Short-term Debt i10.5M10.1M9.8M8.4M5.5M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i11.0M10.8M10.4M8.7M6.8M
Non-Current Liabilities
Long-term Debt i-----
Deferred Tax Liabilities i-----
Other Non-Current Liabilities-----
Total Non-Current Liabilities i10.7M9.4M10.9M9.1M10.9M
Total Liabilities i21.8M20.2M21.3M17.8M17.7M
Equity
Common Stock i114.1M114.1M114.1M114.1M114.1M
Retained Earnings i-1.4B-1.4B-1.3B-1.3B-1.3B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-8.4M-4.0M-2.5M-1.6M-689.9K
Key Metrics
Total Debt i10.5M10.1M9.8M8.4M5.5M
Working Capital i2.3M5.4M8.4M7.4M10.2M

Balance Sheet Composition

Nyrstar N.V Cash Flow Statement

No cash flow data available.

Nyrstar N.V Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -1.71
Forward P/E 0.11
PEG Ratio 0.11

Profitability Ratios

Profit Margin 0.00%
Operating Margin 0.00%
Return on Equity 53.03%
Return on Assets -21.17%

Financial Health

Current Ratio 1.21
Debt to Equity -1.24
Beta 4.64

Per Share Data

EPS (TTM) €-0.04
Book Value per Share €-0.08

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
nyr7.6M-1.71-53.03%0.00%-1.24
Syneos Health 8.0B377.861.29-1.20%-1.30%45.57
Azelis Group NV 3.3B19.641.246.41%4.01%77.22
Solvay SA 3.0B21.732.6111.13%2.81%185.12
Titan Cement 2.8B13.521.5612.28%7.88%36.26
Solvac S.A 2.0B18.860.784.15%2,093,960.00%7.83

Financial data is updated regularly. All figures are in the company's reporting currency.